ORMP

#3822
Oramed Pharmaceuticals Inc.
3.78 USD
-0.53%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
3.78
3.81
Year Range
1.98
3.91
Daily Change
-0.53%
Monthly Change
+10.85%
6 month change
+65.79%
Year Change
+71.04%
Previous Close
3.80
Open
3.81
Bid
Ask
Low
3.78
High
3.81
Volume
8
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
  • Market Capitalization 152.89 M
  • Employee 13
  • Founded 2006
  • CEO Nadav Kidron
  • Website www.oramed.com
  • Headquarter Delaware, United States
  • FIGI BBG000LRYR36
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
1.9
Price to sales ratio
60.45
Dividends per share
0.25
Dividend yield %
8.77

Oramed Pharmaceuticals Inc

Oramed Pharmaceuticals Inc., is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange.

News